Categories: Wire Stories

Zai Lab Announces Change to Virtual Extraordinary General Meeting of Shareholders to be Held on March 28, 2022

SHANGHAI and SAN FRANCISCO, and CAMBRIDGE, Mass., March 23, 2022 (GLOBE NEWSWIRE) — Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), a patient-focused, innovative, commercial-stage, global biopharmaceutical company, today announced that, due to the public health impact of the coronavirus (COVID-19) pandemic and the recent pandemic-related restrictions in Shanghai, the format of the extraordinary general meeting of shareholders (EGM) of Zai Lab Limited has been changed and will be held in a virtual meeting format only. The purpose of the EGM is to consider and vote on a proposal relating to a proposed 1-to-10 share subdivision of the ordinary shares of Zai Lab Limited. As previously announced, the EGM will be held on March 28, 2022 at 8:00 a.m. (U.S. Eastern Time) / 8:00 p.m. (Hong Kong Time).

Shareholders of record of our ordinary shares as of the relevant record date may attend the EGM virtually by visiting our EGM website at�www.virtualshareholdermeeting.com/ZLAB2022SM. Shareholders will need the 16-digit control number included on their proxy card or on the instructions that accompanied their proxy materials. Shareholders are encouraged to log in to this website and pre-register for the EGM before the start time of the meeting. Online check-in will begin 15 minutes prior to the start of the meeting, and shareholders should allow ample time for the online check-in procedures. The proxy materials previously distributed will not be updated to reflect the change in format, but may continue to be used to vote your shares in connection with the EGM.

About Zai Lab

Zai Lab (NASDAQ: ZLAB; HKEX: 9688) is a patient-focused, innovative, commercial-stage, global biopharmaceutical company focused on developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. To that end, our experienced team has secured partnerships with leading global biopharmaceutical companies in order to generate a broad pipeline of innovative marketed products and product candidates. We have also built an in-house team with strong product discovery and translational research capabilities and are establishing a pipeline of proprietary product candidates with global rights. Our vision is to become a leading global biopharmaceutical company, discovering, developing, manufacturing, and commercializing our portfolio in order to impact human health worldwide.

For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.twitter.com/ZaiLab_Global.

For more information, please contact:

Investor Relations: Ron Aldridge / Lina Zhang
+1 (781) 434-8465 / +86 136 8257 6943
ronald.aldridge@zailaboratory.com /lina.zhang@zailaboratory.com

Media: Danielle Halstrom / Xiaoyu Chen
+1 (215) 280-3898 / +86 185 0015 5011
danielle.halstrom@zailaboratory.com / xiaoyu.chen@zailaboratory.com

Source: Zai Lab Limited

Alex

Recent Posts

Carta continues with global expansion in Australia to support the country’s local startup and investor ecosystem

The US-based private capital software platform sets up base in Sydney as part of Investment…

50 mins ago

Mastering exotic currency pairs: trading strategies with global broker Octa

KUALA LUMPUR, MALAYSIA - Media OutReach Newswire - 14 November 2024 - Adding exotic currency…

2 hours ago

SIBUR to Offset Carbon Footprint of Russia’s COP29 Delegation

MOSCOW, RUSSIA - Media OutReach Newswire - 14 November 2024 - SIBUR plans to offset…

2 hours ago

St. George’s University Invites South Korean Students to Apply for January 2025 Intake

SEOUL, SOUTH KOREA - Media OutReach Newswire - 14 November 2024 - St. George’s University…

4 hours ago

Swiss Business Hub: Global Fintechs Thrive on Switzerland’s Tech-Neutral Approach to AI

SINGAPORE - Media OutReach Newswire - 14 November 2024 - In the rapidly evolving landscape…

12 hours ago

CGTN:G20 pushes for global cooperation to eradicate hunger and poverty

BEIJING, CHINA - Media OutReach Newswire - 13 November 2024 - The first-ever Global Alliance…

12 hours ago